Islets of Langerhans from normal mice contained dendritic cells (DCs) in the range of 8 -10 per islet. DCs were found in several mouse strains, including those from lymphocyte-deficient mice. DCs were absent in islets from colony stimulating factor-1 deficient mice and this absence correlated with small size islets. Most DCs were found next to blood vessels and resided in islets for several days. Some DCs contained insulin-like granules, and most expressed peptide-MHC complexes derived from ␤ cell proteins. Islet DCs were highly effective in presenting ␤ cell antigens to CD4 T cells ex vivo. Presentation of ␤ cell-derived peptide-MHC complexes by DCs neither depended on islet inflammation nor correlated with the extent of spontaneous ␤ cell death. Periislet stroma DCs did not contain ␤ cell peptide-MHC complexes; however, 50% of DCs in pancreatic node were positive. Hence, presentation of high levels of ␤ cell antigens normally takes place by islet DCs, a finding that has to be placed in the perspective of autoimmune diabetes.
Strains of either sex were 6 -15 weeks of age, and B6.op/op mice were 4 weeks of age. Two experiments used NOD.scid mice, and the remaining experiments used NOD.rag-1 Ϫ/Ϫ mice. IP-HEL mouse strains were ILK3 and 111. ND, not determined.
CD62P, and CD62E. Pointedly, vessels did not express class II MHC molecules. The close proximity of DCs to the vessel wall was evident when islets were stained for PECAM-1 (shown in red) and CD11c (green) (Fig. 2c) . A number of images showed thin CD11cϩ dendrites colocalizing with vessels (yellow-fluorescence), suggesting that DCs were actively probing the vessel and the surrounding area [ Fig. 2d and supporting information (SI) Movie S1].
Explanted islets were imaged by two-photon (2P) microscopy. Approximately 90% of the DCs during the 20-to 30-min observation period remained close to the blood vessels and showed little if any displacement over time from their starting positions in the islets (migration of Ͻ1 m/min). The DCs featured highly dynamic dendrite activity in situ as they extended and retracted long dendrites between ␤-cells. Approximately 10% were highly motile and moved through the islet into the peripheral areas with less dynamic dendrite activity even escaping from them (migration of 1.5 m/ min) (Movie S1 and Movie S2).
Ultrastructural examination of the islets disclosed the expected granule laden ␤-cells. A few cells with microscopic features compatible with myeloid cells were observed always next to blood vessels: smaller than ␤-cells, a few square shaped, whereas most showed an elongated body shape (Fig. 3 a-d ). This morphology was consistent with the DCs identified by fluorescence microscopy. Most cells had dense cytoplasmic granules, and Ϸ10% contained 1-3 granules, which had a dense core compatible with the insulin granules of ␤-cells (Fig. 3 e and f ) . DC dendrites were often observed in close apposition to the thin endothelial layer.
The CD11c-YFP transgenic mice were also used to evaluate cells in the periislet tissue. We use the term ''stroma'' to define the tissue surrounding islets and acini. In the one experiment, 12
CD11c
ϩ cells per islet were found as an average; the stroma, after islet removal, showed 2.2% positive cells. From these results, the stroma was estimated to contain a total of Ϸ8.4 ϫ 10 4
ϩ cells, whereas islets contained Ϸ3 ϫ 10 3 cells; that is to say, the stroma contained 30 times more DCs than the islets. As detailed below, stroma DCs lacked detectable ␤ cell-derived peptide-MHC complexes. Similar results were found in B10.BR and IP-HEL mice in which the estimated total numbers of stroma CD11cϩ cells were Ϸ1.4 ϫ 10 5 and 9.7 ϫ 10 4 , whereas the islets contained 3.7 ϫ 10 3 and 4 ϫ 10 3 , respectively. The number of DCs was strikingly low in the op/op mice, which have a mutation in the CSF-1 gene (Table 1 ). The CSF-1 receptor is expressed in DCs and the defective mice have a marked reduction in the number of DCs (10) . The distribution was 65% of islets without DCs and 20, 12, and 3% with one, two, and three DCs, respectively. In agreement (10), the islets were small, with a mean area of 18.9 mm 2 , approximately half the size of wild type islets.
Islet APC Under Steady State and Inflammation. Islet APC were remarkably stable in numbers, decreasing only by 30-40% 3 days after whole body irradiation (shielding the upper abdomen with a lead cuff), after which the number did not change up to 7 days of observation (Fig. 4a) . One experiment showed a decrease over a period of 7 days, whereas, in a repeat experiment, numbers remained unchanged.
The role of islet DCs under weak inflammatory conditions was examined by administering low doses of streptozocin (STZ) (11) . NOD.rag-1 Ϫ/Ϫ mice showed a 1.5-fold increase in the numbers of APC by day 4 (12.2 per islet) and a 2-fold increase by day 8 (14.2 per islet) after low-dose STZ treatment (Fig. 4b) . The increase in islet DCs depended on bone marrow function, because mice that received low dose STZ and a sublethal dose of irradiation showed reduced numbers (6.4 and 4 per islet at days 4 and 8, respectively) (Fig. 4b) . Thus, islet DCs have a slow turnover time, and the decrease in their number by day 8 in the sublethally irradiated STZ mice most likely depended on their migration out of the islet. Experiments in progress are evaluating the migration in and out of islets.
Analysis of the DC membrane marker profile before and after STZ treatment revealed that the incoming APC from circulation are B7-2 high-bearing, whereas mice that lack incoming DCs from circulation (STZ plus sublethal irradiation treatment) did not show positive B7-2 DCs in islets. In conclusion, the pool of B7-2 expressing DCs is a discrete population of cells that enter islets from the circulation under inflammatory conditions and is not due to B7-2 up-regulation on islet-resident DCs. Further kinetic analyses combined with transfer of DCs is needed.
Islet APC Contain a ␤ Cell Peptide-MHC Complex. We examined islets from two different IP-HEL mouse strains, both of which were normal by histological criteria and by their content of insulin, determined biochemically (8) . The ILK-3 and the 111 mice express 1.12 ϫ 10 6 , and 7.45 ϫ 10 5 molecules of membrane bound HEL per ␤ cell, respectively (8) . The number of DCs per islet in these two transgenic mice was entirely within the normal range (Table 1) . Approximately 90% of the DCs from IP-HEL islets were positive for the 48-61-I-A k complex when staining with the AW monoclonal antibody (12) , whereas no positive reaction was detected in islets from normal mice, not expressing HEL (Fig. 2e) . The extensive representation of 48-61-I-A k complexes on the DCs from IP-HEL mice suggested that the capture of the HEL was not related to ␤ cell death. TUNEL staining of several frozen sections from IP-HEL mice revealed four islets containing a single positive cell out of 146 that were scanned.
Flow cytometry analysis of isolated stromal cells failed to disclose DCs bearing the 48-61-I-A k complex in IP-HEL mice. Likewise, staining of frozen sections of pancreas from IP-HEL mice also failed to show positive reaction in the APC network found outside islets. [Stromal cells from normal B10.BR also were negative, as expected, but, as a control for the staining reaction, those from mHEL, i.e., mice expressing HEL in their APC, were positive and so were frozen sections from their pancreas (data not shown.)]
Pancreatic lymph nodes contain peptide-MHC complexes from ␤ cell-derived antigens (8, (13) (14) (15) . The route from the islets to the draining node is likely by way of pancreatic lymphatics (16) , which drains either islet DCs or ␤ cell antigens directly. Knowing that islet DCs were rich in peptide-MHC complexes, the display of the complex was also examined in DCs of pancreatic and brachial lymph nodes of IP-HEL mice. Approximately 40-50% of DCs from pancreatic lymph nodes but not from brachial lymph nodes contained the HEL peptide-MHC complex (Fig. 5) . However, attempts to locate HEL as intact protein in the APC, using a monoclonal antibody were negative. DCs from B10.BR mice or from ML-5 mice (17) were negative for 48-61-I-A k complexes. ML-5 expresses HEL under the methalotheinin promoter and have Ϸ10 ng/ml in blood (17, 18) ; previous studies had shown that their APC contained barely detectable peptide-MHC complexes and did not present HEL to CD4 T cells (19) .
In essence, we conclude that a large number of the DC of the draining nodes contain ␤ cell-derived-MHC complexes. Most likely, the DCs in the pancreatic lymph node derived from those in the islets migrating by way of the lymphatics.
Islet APC Present Antigen in ex Vivo Assays. The islet DCs from either NOD or IP-HEL mice contained specific peptide-MHC complexes that were presented to a variety of CD4 T cells. T cell hybridomas were used in all our experiments. Fig. 6a shows that the BDC2.5 T cells that recognize an unknown ␤ cell antigen (20) were activated when incubated with dispersed islet cells from NOD.rag-1 Ϫ/Ϫ mice. Consistently, presentation was at its optimum at 10 4 islet cells per culture, but the response decreased when the number was increased. Antigen presentation was abolished by incubation with a monoclonal antibody to I-A g7 . Fig. 6b shows the presentation by islet cells from NOD mice to an insulin T cell hybridoma. Likewise, both the 3A9 T cell directed to the dominant 48-61-I-A k complex, and the LB11 T cell directed to the lesser expressed 20-35-I-A k complex (21) were activated by incubation with disrupted islet cells from IP-HEL mice, either ILK-3 or 111 (Fig. 6c) . The IP-HEL transgenic mouse line 117 expressing low amounts of HEL, 5 ϫ 10 4 HEL per ␤ cell (8), also stimulated the 3A9 T cells, a further indication that the islet DCs are highly effective at antigen presentation. No increase in presentation was found by using islets from IP-HEL mice treated with STZ (Fig. 6d) .
Discussion
Our findings confirmed the presence of DCs within the islets of Langerhans, established their phenotype and two important and unique features of them, relevant in the perspective of autoimmune diabetes. First, the DCs expressed high levels of ␤ cellderived peptide-MHC complexes with the potential of being presented to T cells. Second, this presentation was not correlated with overt cell death nor inflammation.
Features. Islet DCs expressed CD11c and CD11b and F4/80 and displayed class II MHC molecules. Although B7-1 was clearly detected, B7-2 molecules were found very weakly. We could not identify other distinguishing features. Islet DCs can therefore be classified as immature. In a previous study, we found that DCs, also classified as immature, had processed HEL to peptide-MHC complexes (22) . A striking feature of the islet DCs was their close association with vessels and the intimate contact between the endothelial cells and the DC dendrites. We detected instances in which the DC dendrites were closely plastered next to the endothelial cell fenestrae. Other finding was made with the CSF-1 mutant mice, which lacked islet DCs and had small islets with reduced ␤ cell mass (10) . The finding suggests a trophic role of the islet DCs in ␤ cell function. Finally, experiments in progress are analyzing the mechanisms of entry and disappearance of mononuclear phagocytes into islets. The turnover rate of islet DCs was relatively slow. In heavily irradiated mice, a substantial number of them remained in the islet for at least 7 days. Islets have been shown to express a number of chemokines, which may modulate the entry of DCs into them (23, 24) .
Antigen Presentation: The Draining Node. We suggest that it is the islet DC that is responsible for the interaction with T cells as it takes up antigen and migrates to the draining node. The ␤ cell-derived peptide-MHC complex was detected without any manipulation of the islet without the need of an overt inflammatory reaction or death program, as was evident in the IP-HEL or NOD.rag-1 Ϫ/Ϫ mice. The close contact between the DC and the ␤ cell likely resulted in the uptake of proteins from the latter, most likely proteins derived from the insulin granule. The ultrastructural analysis disclosed granules identical to those in ␤-cells in some of the DCs. [Ultrastructural studies of inflamed islets document the presence of insulin or insulin granules inside mononuclear cells (25, 26) ].
The efficiency of the DC in capturing ␤ cell proteins can be estimated by comparing them to conventional DCs pulsed with protein antigens. In many experiments, as few as 10,000 islet cells stimulated the T cells, including the results testing the IP-HEL 117 line (8) , which expresses low levels of HEL in their ␤-cells (Fig. 6d) . Because the DCs represent no more than 1% of the total cells per islet, the number of DCs per culture should be Ϸ100, an indication that each DC must be heavily loaded with the peptide-MHC complex in order for them to stimulate the T cell hybridomas. In standard experiments, DCs had to be pulsed with low micromolar concentrations of proteins to present to the level found in islets (data not shown). These concentrations may be feasible in vivo given the close anatomy in the islets of the two cells involved in the presentation. An estimate of the efficiency of antigen uptake can be made with the IP-HEL mice. Assuming that 3A9 T cells are activated by at least 10 peptide-MHC complexes (27) and that 10 3 HEL molecules yield one peptide-MHC complex (12) , the minimal number of HEL molecules captured by the DCs should be 10 4 . For example, the 117 line expressed 5 ϫ 10 4 HEL molecules per ␤ cell (8), indicating at a given time a total of HEL molecules per islet of 5 ϫ 10 7 , of which at least 10 6 are in APC (i.e., 10 APC per islet, each having 10 4 HEL molecules), that is, Ϸ2% of the islet content of the antigen.
The high content of peptide-MHC complexes derived from ␤ cell proteins in islet DCs makes them a candidate for the interactions that takes place in the pancreatic node. The draining node is known to contain peptide-MHC complexes derived from ␤-cells: Naïve T cells specifically proliferate at that site and are activated (14, 15) ; mice in which the draining node was removed surgically (28) or ablated by genetic manipulations (29) did not develop diabetes or generate diabetogenic CD4 T cells. But by what mechanism does the draining node concentrate ␤ cellderived peptide-MHC in their APC? Selective trapping in the pancreatic node of ␤ cell proteins released into the blood circulation or into the stroma would not make an efficient and selective mechanism of concentration of antigen. Indeed, mice having a level of circulating HEL much larger than IP-HEL did not show positive DCs in islets. Antigens directly injected into the pancreas drained to that site (30) , and APC have been detected containing ␤ cell proteins (13) . These findings indicate that the most logical pathway of entry to the pancreatic nodes is by cells coming directly from the pancreas via the draining lymphatics.
Our results with IP-HEL suggest a scenario in which the islet DC, which is the major-if not the only-DC having the ␤ cell-derived peptide-MHC complexes, migrate out into the peri-islet stroma and from there into the lymphatics that drain into the local node. This process is independent of ␤ cell injury, although it could well be fostered by it (30) (31) (32) . The islet DCs in the draining node could present the peptide-MHC complex directly or be involved in DC-DC interactions. Importantly, in the context of a chronic autoimmune disease, the DCs could also be involved in interactions that foster regulatory T cells. In summary, islet DCs are normally heavily charged with ␤ cellderived peptide-MHC complexes irrespective of the physiological state of the islet, i.e., whether normal or inflamed. It represents a challenge to the immune system to maintain a homeostatic balance in which the DC with its content of specific peptide-MHC and the complementary T cells are held in check. In this regard, that the DCs are heavily loaded with peptide-MHC complexes and bear an immature phenotype needs to be kept under consideration. Finally, it will be important to examine the islet DCs in the spontaneous diabetic process of the NOD mouse and determine whether there are changes associated with them as the disease develops.
Materials and Methods
Mice. All mice were bred at our facility or obtained from The Jackson Laboratory. B10.BR mouse strains expressing the HEL gene under the insulin promoter (IP-HEL) included the ILK-3 (7) T Cells. CD4 T cells were used as T cell hybridomas. The specificity of 3A9 is against the chemically dominant peptide of the protein HEL residues 48-61 presented by I-A k molecules (21) . LB.11 is against a minor determinant of HEL, residues 20 -35, which is also presented by I-A k molecules (21) . BDC2.5 is against an unknown ␤ cell antigen presented by I-A g7 molecules (20, 33) . 4E4 is a hybridoma that recognizes the insulin peptide B: (9 -23) bound to I-A g7 molecules.
Islet Isolation and Handling. Islets were isolated by modifications (34) of the original protocol (35) . Briefly, pancreata were isolated and treated with collagenase, followed by several steps of centrifugation and washing, and, finally, islets were hand picked. To visualize islet APC, islets were incubated with two antibody reagents at the same time (50 -100 islets) in 50 l of DMEM with 10% FCS, using the antibodies at 40 -100 g/ml. After 60 min, islets were washed free of the antibody. Streptavidin Texas red-X conjugate or Alexa Fluor 555 (Invitrogen) for 30 min at room temperature was used as a secondary step. Islets were fixed in 2% paraformaldehyde before examination. To analyze the pancreatic tissue (the stroma), the supernatants from the tissue not captured in the cell strainer during the islet isolation procedure (only islets are retained in the cell strainer) were collected, washed, and resuspended in DMEM with 5% FCS plus 0.5 mM EDTA. Cells were stained with antibodies (Table S1 ) and examined by flow cytometry, using FACS Calibur, and data were analyzed by FlowJo (Tree Star).
Microscopy Analysis. Islets were examined in a standard fluorescent microscope with epi-illumination or under a 2P microscope. Cell numbers were counted for each cell marker and images were captured at ϫ20 magnification, using SPOT Slider microscope digital camera and software (Diagnostic Instruments). Islet area was calculated by using the ellipse area formula: Area ϭ ( ϫ A ϫ B)/4. For 2P microscopy, islets were attached to a coverslip with Cell-Tak (BD Biosciences), submerged in Connaught Medical Research Laboratories (CMRL) medium 1066 (Invitrogen), and maintained at 37°C. 2P imaging was performed with an Olympus BX51WI fluorescence microscope equiped with a 20ϫ objective (Olympus) controlled by Image Warp software (BitFlow) (36) . For 2P excitation and second harmonic generation, two COHERETT Chameleon lasers were used and tuned to 915 nm for the detection of yellow fluorescent protein, CFSE, or Alexa Fluor 555 and 710 nm for detection of second harmonic excitation. For three-dimensional islet analysis, stacks of 60 squared x-y sections with 2.5-m z spacing were acquired every 90 s for a total time of 15-25 min, with electronic zooming up to 1ϫ to provide image volumes of x ϭ 279.3 m, y ϭ 313.6 m, and z ϭ 118 m. Image stacks were transformed into volume-render three-dimensional movies or images, using Imaris x64 software, Version (beta2)5.0.2 (Bitplane AG).
Electron Microscopy. Pancreata were fixed by blood vessel perfusion with modified Karnovsky's fixative for 24 h as reported in ref. 25 . Islets were also examined after isolation and fixation in modified Karnovsky's.
Antibody Reagents. A detailed summary of antibodies used is listed in Table S1 . Secondary staining reagents were used at a concentration of 40 g/ml. For 2P microscopy, islets were stained with azide free biotinylated antibodies. For flow cytometry analysis, islet DCs were surface stained for membrane chemokine receptors; pancreatic and braquial lymph node cells were surface stained for CD11c and 48 -61-I-A k . Detection of intracellular HEL in pancreatic lymph node DCs was performed by intracellular staining with anti-HEL antibody (37) .
Antigen Presentation. In IP-HEL mice, the intact islets were examined for the presence of peptide-MHC complex, using the AW antibody specific for the HEL 48 -61-I-A k complex (12) . A second approach for IP-HEL and NOD.rag-1 Ϫ/Ϫ islets consisted of testing functionally the islet APC for presentation. Isolated islets were disrupted by treatment with trypsin solution in a 37°C water bath for 3 min and then washed in CMRL medium 1066 several times. The dispersed cellular preparation was then added to T cell hybridomas (2 ϫ 10 4 cells) and incubated for 24 h, after which the production of IL-2 was determined. For NOD.rag-1 Ϫ/Ϫ islets, dispersed ␤-cells were culture with either the BDC 2.5 hybridoma or with T cell hybridomas for insulin (clone 4E4). Supernatant was removed at 24 h to test for IL-2 measured with a standard cytotoxic T lymphocyte line assay as described.
Statistical Analysis. The Mann-Whitney U test was used to determine level of significant differences in sample means.
